MENU
TCRT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alaunos Therapeutics (TCRT) Ownership - Who owns Alaunos Therapeutics?
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
2617 Bissonnet Street
Phone
+1 346 355-4099
Employees
1
Web
https://www.alaunos.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.41M
P/E Ratio
N/A
Total Cash
319K
Projected Growth
N/A
Total Debt
N/A
Revenue
11K
Risk (Beta)
-1.78
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
TCRT
Capitalization
8.41M
P/E Ratio
N/A
Risk (Beta)
-1.78
Dividend Yield
N/A
Total Cash
319K
Total Cash/Share
0.19
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
11K
ROE
N/A
Book Value
1.06M
P/B Ratio
7.95
Cash Flow
N/A
Earnings
-2.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
1.00
Current Revenue Per Employee
2000.00
Dividends Per Share - Security
N/A
EBITDA
-4.03M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-99.79
Shares Held By Institutions
247K
Shares Outstanding - Current
1.64M
Total Liabilities
1.06M
Total Volume MTD
N/A
Value
-1
Gain YTD
169.291
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a cancer treatment company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2617 Bissonnet Street
Phone
+1 346 355-4099
Employees
1
Web
https://www.alaunos.com